MedPath

Feeding Trial in Pediatric Patients

Completed
Conditions
Developmental Disabilities
Interventions
Other: enteral formula
Registration Number
NCT01469117
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This is a single center, prospective, non-randomized, uncontrolled, observational study of the use of an enteral nutrition product in pediatric patients with developmental disabilities.

Detailed Description

This prospective observational study seeks to assess ability to achieve enteral feeding goals with a new tube feeding product in pediatric patients with developmental disabilities.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Child aged 1-13 years old with development disabilities
  • Currently tolerating enteral feeding
  • Requiring nutritional management to meet 50-90th% weight for age on the Kennedy Kreiger Growth Charts
  • Requires enteral tube feeding for at least 14 days.
Exclusion Criteria
  • Unable to access gastrointestinal tract for feeding via tube
  • Other condition which contraindicates tube feeding

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pediatric developmental disabilitiesenteral formulaChildren aged 1-13 years old with development disabilities, requiring enteral tube feeding for at least 14 days
Primary Outcome Measures
NameTimeMethod
Time to feeding goal achievementup to 14 days
Secondary Outcome Measures
NameTimeMethod
Percentage of nutrition goal metdaily up to 21 days
Gastrointestinal measures assessmentup to 21 days
Serum biochemical markers assessmentbaseline and completion of study
Assessment of frequency and nature of adverse eventsdaily up to 21 days

Trial Locations

Locations (1)

The Children's Center

🇺🇸

Bethany, Oklahoma, United States

© Copyright 2025. All Rights Reserved by MedPath